CXCL10 and COVID-19: Additionally, COVID-19 patients had increases in inflammatory biomarkers such as IP10 (median 429.1 vs 22.4pg/mL), IL-10 (median 9.3 vs. 1.3pg/mL), and RAGE (median 2476 vs. 686pg/mL), when compared to disease controls.